YU52200A - Halogenisani amidino-amino-kiselinski derivati koji se koriste kao inhibitori azot-monoksid sintetaze - Google Patents

Halogenisani amidino-amino-kiselinski derivati koji se koriste kao inhibitori azot-monoksid sintetaze

Info

Publication number
YU52200A
YU52200A YU52200A YU52200A YU52200A YU 52200 A YU52200 A YU 52200A YU 52200 A YU52200 A YU 52200A YU 52200 A YU52200 A YU 52200A YU 52200 A YU52200 A YU 52200A
Authority
YU
Yugoslavia
Prior art keywords
amino acid
acid derivatives
nitric oxide
oxide synthase
synthase inhibitors
Prior art date
Application number
YU52200A
Other languages
English (en)
Inventor
Ann Hallinan
Barnett Pitzel
Dale Spangler
Arija Bergmanis
Timothy Hagen
Sofya Tsymbalov
Mihaly Toth
Keith Webber
Donald Hansen Jr.
Alik Awasthi
Original Assignee
G.D. Searle & Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by G.D. Searle & Co. filed Critical G.D. Searle & Co.
Publication of YU52200A publication Critical patent/YU52200A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/14—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)

Abstract

Predmetni pronalazak se odnosi na halogenisane amidino-amino-kiselinske derivate koji se koriste kao inhibitori azot-monoksid sintetaze i koji imaju formulu (I), ili na njihove farmaceutski prihvatljive soli, a čiji su svi supstituenti izloženi u opisu ovog pronalaska.[Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors of Formula (I) or a pharmaceutically acceptable salt thereof, wherein all substituents are described in the specification.
YU52200A 1998-03-11 1999-03-04 Halogenisani amidino-amino-kiselinski derivati koji se koriste kao inhibitori azot-monoksid sintetaze YU52200A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3828498A 1998-03-11 1998-03-11

Publications (1)

Publication Number Publication Date
YU52200A true YU52200A (sh) 2002-09-19

Family

ID=21899068

Family Applications (1)

Application Number Title Priority Date Filing Date
YU52200A YU52200A (sh) 1998-03-11 1999-03-04 Halogenisani amidino-amino-kiselinski derivati koji se koriste kao inhibitori azot-monoksid sintetaze

Country Status (35)

Country Link
US (1) US6344483B1 (sh)
EP (2) EP1415982A1 (sh)
JP (1) JP2002506056A (sh)
KR (1) KR20010034598A (sh)
CN (1) CN1171861C (sh)
AP (1) AP2000001900A0 (sh)
AR (1) AR018159A1 (sh)
AT (1) ATE277894T1 (sh)
AU (1) AU746235B2 (sh)
BG (1) BG104766A (sh)
BR (1) BR9908702A (sh)
CA (1) CA2322873A1 (sh)
CU (1) CU23047A3 (sh)
DE (1) DE69920670T2 (sh)
EA (1) EA200000826A1 (sh)
EE (1) EE200000519A (sh)
ES (1) ES2239839T3 (sh)
GE (1) GEP20043179B (sh)
HR (1) HRP20000595A2 (sh)
HU (1) HUP0101467A3 (sh)
ID (1) ID26208A (sh)
IL (1) IL137654A0 (sh)
IS (1) IS5583A (sh)
NO (1) NO20004531L (sh)
NZ (1) NZ506721A (sh)
OA (1) OA11901A (sh)
PL (1) PL343380A1 (sh)
PT (1) PT1062201E (sh)
SI (1) SI1062201T1 (sh)
SK (1) SK13012000A3 (sh)
TR (1) TR200002605T2 (sh)
UA (1) UA67767C2 (sh)
WO (1) WO1999046240A2 (sh)
YU (1) YU52200A (sh)
ZA (1) ZA991894B (sh)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4216502B2 (ja) 2000-03-24 2009-01-28 ファルマシア コーポレーション 酸化窒素シンターゼ阻害剤として有用なアミジノ化合物
US6956131B2 (en) * 2000-04-13 2005-10-18 Pharmacia Corporation 2-amino-3, 4 heptenoic compounds useful as nitric oxide synthase inhibitors
AR034120A1 (es) 2000-04-13 2004-02-04 Pharmacia Corp Compuesto derivado halogenado del acido 2-amino-4,5 heptenoico, composicion farmaceutica que lo comprende y el uso de dicho compuesto y dicha composicion en la fabricacion de un medicamento para inhibir o modular la sintesis de acido nitrico
AR030416A1 (es) 2000-04-13 2003-08-20 Pharmacia Corp COMPUESTO DERIVADO HALOGENADO DEL ACIDO 2-AMINO-3,4 HEPTENOICO, COMPOSICION FARMACEUTICA QUE LO COMPRENDE Y SU USO EN LA FABRICACION DE UN MEDICAMENTO uTIL COMO INHIBIDOR DE LA OXIDO NITRICO SINTETASA
US6787668B2 (en) 2000-04-13 2004-09-07 Pharmacia Corporation 2-amino-4,5 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
AR032318A1 (es) * 2000-04-13 2003-11-05 Pharmacia Corp Compuesto derivado halogenado del acido 2-amino-5,6 heptenoico; composicion farmaceutica que lo comprende y su uso en la fabricacion de un medicamento util como inhibidor de la oxido nitrico sintetasa
US6545170B2 (en) 2000-04-13 2003-04-08 Pharmacia Corporation 2-amino-5, 6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
AR035585A1 (es) * 2000-09-15 2004-06-16 Pharmacia Corp Derivados del acido 2-amino-2-alquil-4-heptenoico, composicion farmaceutica y su uso en la fabricacion de medicamentos
AR031609A1 (es) * 2000-09-15 2003-09-24 Pharmacia Corp Derivados de acido 2-amino-2-alquil-3 heptenoico y heptinoico utiles como inhibidores de oxido nitrico sintetasa
AR031129A1 (es) 2000-09-15 2003-09-10 Pharmacia Corp Derivados de los acidos 2-amino-2-alquil-4-hexenoico y -hexinoico utiles como inhibidores de oxido nitrico sintetasa
AR031608A1 (es) * 2000-09-15 2003-09-24 Pharmacia Corp Derivados de los acidos 2-amino-2-alquil-3-hexenoico y -hexinoico utiles como inhibidores de oxido nitrico sintetasa
GB0031179D0 (en) 2000-12-21 2001-01-31 Glaxo Group Ltd Nitric oxide synthase inhibitors
US6613280B2 (en) * 2001-03-20 2003-09-02 Therox, Inc. Disposable cartridge for producing gas-enriched fluids
US6582387B2 (en) * 2001-03-20 2003-06-24 Therox, Inc. System for enriching a bodily fluid with a gas
US7012098B2 (en) 2001-03-23 2006-03-14 Pharmacia Corporation Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers
BR0310061A (pt) * 2002-05-16 2005-03-01 Pharmacia Corp Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições
SG158148A1 (en) 2004-12-22 2010-01-29 Ambrx Inc Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
KR101280929B1 (ko) * 2005-03-14 2013-07-01 얀센 파마슈티카 엔.브이. 오피오이드 모듈레이터의 제조방법
PL1954710T3 (pl) 2005-11-08 2011-09-30 Ambrx Inc Przyspieszacze do modyfikacji aminokwasów niewystępujących w przyrodzie i polipeptydów zbudowanych z aminokwasów nie występujących w przyrodzie
CA2882445A1 (en) * 2005-12-14 2007-06-21 Ambrx, Inc. Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
KR101103720B1 (ko) * 2011-06-02 2012-01-11 한국건설기술연구원 자연환기에 의한 중공층의 온도제어가 가능한 일체형 다중유리 복합창짝
EP3043810B1 (en) 2013-09-09 2019-10-23 CanImGuide Therapeutics AB Immune system modulators
WO2016144650A1 (en) 2015-03-06 2016-09-15 Canimguide Therapeutics Ab Immune system modulators and compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9127376D0 (en) * 1991-12-24 1992-02-19 Wellcome Found Amidino derivatives
GB9312761D0 (en) * 1993-06-21 1993-08-04 Wellcome Found Amino acid derivatives
ES2145282T3 (es) 1994-06-15 2000-07-01 Wellcome Found Inhibidores de enzimas.
GB9425701D0 (en) * 1994-12-20 1995-02-22 Wellcome Found Enzyme inhibitors
US5981511A (en) * 1996-03-06 1999-11-09 G.D. Searle & Co. Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
US5945408A (en) * 1996-03-06 1999-08-31 G.D. Searle & Co. Hydroxyanidino derivatives useful as nitric oxide synthase inhibitors

Also Published As

Publication number Publication date
AU746235B2 (en) 2002-04-18
AR018159A1 (es) 2001-10-31
AP2000001900A0 (en) 2000-09-30
UA67767C2 (uk) 2004-07-15
CN1292779A (zh) 2001-04-25
EP1415982A1 (en) 2004-05-06
JP2002506056A (ja) 2002-02-26
HRP20000595A2 (en) 2001-04-30
GEP20043179B (en) 2004-02-25
PL343380A1 (en) 2001-08-13
CU23047A3 (es) 2005-04-26
OA11901A (en) 2006-04-10
EP1062201B1 (en) 2004-09-29
ATE277894T1 (de) 2004-10-15
SK13012000A3 (sk) 2001-06-11
NO20004531D0 (no) 2000-09-11
DE69920670T2 (de) 2006-02-16
EA200000826A1 (ru) 2001-04-23
CN1171861C (zh) 2004-10-20
DE69920670D1 (de) 2004-11-04
CA2322873A1 (en) 1999-09-16
NZ506721A (en) 2003-07-25
NO20004531L (no) 2000-10-30
PT1062201E (pt) 2005-02-28
WO1999046240A2 (en) 1999-09-16
TR200002605T2 (tr) 2000-12-21
EP1062201A2 (en) 2000-12-27
AU2778699A (en) 1999-09-27
IL137654A0 (en) 2001-10-31
IS5583A (is) 2000-08-04
US6344483B1 (en) 2002-02-05
ID26208A (id) 2000-11-07
KR20010034598A (ko) 2001-04-25
HUP0101467A2 (hu) 2001-08-28
WO1999046240A3 (en) 1999-11-11
SI1062201T1 (en) 2005-10-31
BR9908702A (pt) 2000-11-21
EE200000519A (et) 2002-02-15
ES2239839T3 (es) 2005-10-01
ZA991894B (en) 1999-09-27
BG104766A (bg) 2001-03-30
HUP0101467A3 (en) 2003-03-28

Similar Documents

Publication Publication Date Title
AP2000001900A0 (en) Halogeneted amidino amino acid derivatives useful as nitric oxide synthase inhibitors.
JO2311B1 (en) Alkyl inhibitors Ariel phosphodiesterase-4
IL148313A0 (en) N-heterocyclic derivatives as nos inhibitors
RS92004A (en) Pyrrolo-triazine aniline compounds useful as kinase inhibitors
AU4798000A (en) Triarylimidazoles
WO2003013484A3 (en) N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents
GEP20074099B (en) 3-β-D-RIBOFURANO-SYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
MXPA02003977A (es) Inhibidores de adhesion de celula mediada por al°2.
NO20052182L (no) Nye forbindelser
MXPA03010761A (es) Combinaciones farmaceuticas.
AU2003250471A1 (en) Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors
WO2000005214A3 (en) Isoquinolines as urokinase inhibitors
MY140164A (en) Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
WO2001081316A3 (en) Substituted phenyl farnesyltransferase inhibitors
CA2412596A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
SE9803773D0 (sv) Compounds
CA2317604A1 (en) Matrix metalloprotease inhibitors
MXPA02004441A (es) Derivados de isoxazol como inhibidores de la fosfodiesterasa.
EP1325903A4 (en) DERIVATIVES OF 2,3-DIPHENYLPROPIONIC ACID OR THEIR SALTS, MEDICAMENTS OR INHIBITORS OF CELL ADHESION CONTAINING THE SAME, AND THEIR USE
EP1219296A4 (en) SEBUM PRODUCTION INHIBITORS
WO2003076429A3 (en) Azepane derivatives and their use as atk1 inhibitors
EP1118615A4 (en) PYRIDOPYRAZINE DERIVATIVES SALTS AND CRYSTALS THEREOF
AU2002218233A1 (en) N-substituted amino acid derivatives (factor xa inhibitors)
DE60014915D1 (de) Hypoxanthin- und thiohypxanthin-verbindungen
AU4446500A (en) 5,7-bicyclic amidine derivatives useful as nitric oxide synthase inhibitors